https://www.scmp.com/news/china/science/article/3192823/china-records-first-monkeypox-case?utm_term=Autofeed&utm_medium=Social&utm_content=article&utm_source=Twitter#Echobox=1663339580
The infected patient, who had arrived in Chongqing from overseas, developed symptoms while in Covid quarantine
https://clinicaltrials.gov/ct2/show/NCT05543681
Brief Summary:
This is a superiority, parallel group, double blinded, randomized, powered, multi-site, and placebo-controlled study.
Ages 60 and above
Quince Therapeutics, Inc. (NASDAQ:QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, today detailed highlights from the company's participation at
CAMBRIDGE, Mass. and TARRYTOWN, N.Y., Sept. 16, 2022 /PRNewswire/ -- Intellia Therapeutics, Inc. (NASDAQ: NTLA) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced positive interim
- Oral poster showcasing positive results from Revance's Phase 2 JUNIPER clinical trial, which demonstrated long-term efficacy and safety with DAXXIFY™ for the treatment of upper limb spasticity (ULS)
Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", , Sorrento", , )))) today announced publication of peer-reviewed data detailing the discovery and preclinical profiling of antibodies from the Sorrento